Novo Nordisk
NVO
#78
Rank
HK$1.655 T
Marketcap
HK$372.57
Share price
-0.27%
Change (1 day)
-55.29%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Net assets

Net assets on the balance sheet as of September 2025 : HK$207.96 Billion

According to Novo Nordisk's latest financial reports the company has HK$207.96 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novo Nordisk - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$HK$155.43 B26.1%
2023-12-31$HK$123.25 B31.22%
2022-12-31$HK$93.93 B11.85%
2021-12-31$HK$83.98 B3.5%
2020-12-31$HK$81.14 B20.66%
2019-12-31$HK$67.25 B8.13%
2018-12-31$HK$62.19 B-0.87%
2017-12-31$HK$62.74 B26.24%
2016-12-31$HK$49.70 B-6.83%
2015-12-31$HK$53.34 B4.51%
2014-12-31$HK$51.04 B-16.47%
2013-12-31$HK$61.11 B9.44%
2012-12-31$HK$55.84 B10.21%
2011-12-31$HK$50.66 B-1.3%
2010-12-31$HK$51.33 B-3.81%
2009-12-31$HK$53.37 B11.27%
2008-12-31$HK$47.97 B-2.44%
2007-12-31$HK$49.16 B18.34%
2006-12-31$HK$41.54 B22.66%
2005-12-31$HK$33.87 B-10.28%
2004-12-31$HK$37.75 B13.85%
2003-12-31$HK$33.16 B19.78%
2002-12-31$HK$27.68 B14.02%
2001-12-31$HK$24.28 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Pfizer
PFE
HK$724.71 B 248.48%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$185.66 B-10.72%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
HK$144.79 B-30.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$671.78 B 223.03%๐Ÿ‡ซ๐Ÿ‡ท France